| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 87M90CV8NC |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | IgG receptor FcRn large subunit p51 antagonist |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Myasthenia Gravis | 3 | D009157 | ClinicalTrials |
| Erythroblastosis, Fetal | 3 | D004899 | ClinicalTrials |
| Thrombocytopenia | 3 | D013921 | ClinicalTrials |
| Lupus Nephritis | 2 | D008181 | ClinicalTrials |
| Arthritis, Rheumatoid | 2 | D001172 | ClinicalTrials |
| Myositis | 2 | D009220 | ClinicalTrials |
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 2 | D020277 | ClinicalTrials |
| Anemia, Hemolytic, Autoimmune | 2 | D000744 | ClinicalTrials |
| Sjogren's Syndrome | 2 | D012859 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4594310 |
| FDA SRS | 87M90CV8NC |
CONTENTS